Performance Outcomes

临床试验

计划入组 134 人 · 首次发布于 2021 年 2 月 10 日

已完成

NCT05942664

Sleeping Habits on Performance Following Sleep Deprivation

计划入组 22 人 · 首次发布于 2023 年 7 月 12 日

已完成

NCT06406907

Effects of Short Duration Blood Flow Restriction Training on Musculoskeletal and Performance Outcomes

计划入组 68 人 · 首次发布于 2024 年 5 月 9 日

药物

查看全部 5 →

Small Molecule

Approved

Nimodipine(Nimotop, Nymalize)

生产企业：Banner pharmacaps inc, Barr laboratories inc，另有 2 家

相关疾病：Delayed Ischemic Neurological Deficit

C₂₁H₂₆N₂O₇ · Rx

peptide

CJC-1295

Small Molecule

Experimental

Inosine(Rejuvesol)

C₁₀H₁₂N₄O₅

机构

查看全部 43 →

NEURO PERFORMANCE INTEGRATION

United States

Neurocore Brain Performance Center

United States

CIMBAR PERFORMANCE MINERALS, INC.

United States

资讯

查看全部 16773 →

9个月前

FDA Issues Updated Patient-Focused Drug Development Guidance on Clinical Outcome Assessments

去年

Active Breaks Show Promise in Boosting Academic Performance for Children with and without ADHD

3个月前

临床试验

Performance Assessement for Paralympic Athletes

Sleeping Habits on Performance Following Sleep Deprivation

Effects of Short Duration Blood Flow Restriction Training on Musculoskeletal and Performance Outcomes

药物

Nimodipine(Nimotop, Nymalize)

CJC-1295

Inosine(Rejuvesol)

机构

NEURO PERFORMANCE INTEGRATION

Neurocore Brain Performance Center

CIMBAR PERFORMANCE MINERALS, INC.

资讯

FDA Issues Updated Patient-Focused Drug Development Guidance on Clinical Outcome Assessments

Active Breaks Show Promise in Boosting Academic Performance for Children with and without ADHD

Nyra Medical Wins 2026 Jon DeHaan Foundation Award for Novel Mitral Valve Repair Technology